GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $490,000 | +114.9% | 7,200 | +0.9% | 0.00% | – |
| Q2 2022 | $228,000 | +3.6% | 7,134 | -0.3% | 0.00% | – |
| Q1 2022 | $220,000 | -2.2% | 7,152 | -7.0% | 0.00% | – |
| Q4 2021 | $225,000 | -13.8% | 7,688 | +3.1% | 0.00% | – |
| Q2 2021 | $261,000 | -8.1% | 7,457 | +7.0% | 0.00% | – |
| Q1 2021 | $284,000 | -5.3% | 6,967 | +0.4% | 0.00% | – |
| Q4 2020 | $300,000 | -2.3% | 6,936 | +24.7% | 0.00% | – |
| Q3 2020 | $307,000 | -15.2% | 5,561 | -3.1% | 0.00% | – |
| Q2 2020 | $362,000 | -44.0% | 5,739 | -54.6% | 0.00% | -100.0% |
| Q1 2020 | $646,000 | -8.8% | 12,644 | +42.0% | 0.00% | 0.0% |
| Q4 2019 | $708,000 | +108.2% | 8,903 | +27.0% | 0.00% | – |
| Q3 2019 | $340,000 | – | 7,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |